About Amphoterin-induced protein 2
Amphoterin-induced protein 2 (AMIGO2) is a protein
from Homo sapiens identified by UniProt accession
Q86SJ2, 522 residues long.
MolForge cross-references it against 0 known binders and
96 disease associations.
Target properties
| Protein name | Amphoterin-induced protein 2 |
| UniProt accession | Q86SJ2 |
| Gene | AMIGO2 |
| Organism | Homo sapiens |
| Length | 522 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (96)
Diseases linked to this target (Open Targets).
- chemotherapy-induced cytotoxicity measurement · score 0.34
- sex interaction measurement · score 0.25
- omega-3 polyunsaturated fatty acid measurement · score 0.25
- PHF-tau measurement · score 0.11
- cancer · score 0.10
- skin pigmentation · score 0.08
- neoplasm · score 0.08
- urinary bladder carcinoma · score 0.07
- gonorrhea · score 0.07
- breast cancer · score 0.05
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q86SJ2-F1 | alphafold | PREDICTED | 75.09 | — |
Amino-acid sequence (522 residues)
MSLRVHTLPT LLGAVVRPGC RELLCLLMIT VTVGPGASGV CPTACICATD IVSCTNKNLS KVPGNLFRLI KRLDLSYNRI GLLDSEWIPV SFAKLNTLIL RHNNITSIST GSFSTTPNLK CLDLSSNKLK TVKNAVFQEL KVLEVLLLYN NHISYLDPSA FGGLSQLQKL YLSGNFLTQF PMDLYVGRFK LAELMFLDVS YNRIPSMPMH HINLVPGKQL RGIYLHGNPF VCDCSLYSLL VFWYRRHFSS VMDFKNDYTC RLWSDSRHSR QVLLLQDSFM NCSDSIINGS FRALGFIHEA QVGERLMVHC DSKTGNANTD FIWVGPDNRL LEPDKEMENF YVFHNGSLVI ESPRFEDAGV YSCIAMNKQR LLNETVDVTI NVSNFTVSRS HAHEAFNTAF TTLAACVASI VLVLLYLYLT PCPCKCKTKR QKNMLHQSNA HSSILSPGPA SDASADERKA GAGKRVVFLE PLKDTAAGQN GKVRLFPSEA VIAEGILKST RGKSDSDSVN SVFSDTPFVA ST
Explore Amphoterin-induced protein 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets